Sign up to save your podcasts
Or
Share E160 - Ongoing challenges of off-label prescribing
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E160 - Ongoing challenges of off-label prescribing
Jo Cheah chats with clinical pharmacologist Richard Day about off-label prescribing. Ric explains why off-label prescribing occurs, the barriers to getting new indications added to a drug’s approved label, and the potential risks of off-label prescribing without sufficient evidence. Read the full article by Richard Day in Australian Prescriber.
View all episodes
By Australian Prescriber
4.5
1414 ratings
Jo Cheah chats with clinical pharmacologist Richard Day about off-label prescribing. Ric explains why off-label prescribing occurs, the barriers to getting new indications added to a drug’s approved label, and the potential risks of off-label prescribing without sufficient evidence. Read the full article by Richard Day in Australian Prescriber.
More shows like Australian Prescriber Podcast
View all
JAMA Clinical Reviews
500 Listeners
Medicine and Science from The BMJ
39 Listeners
Conversations
892 Listeners
All In The Mind
757 Listeners
Health Report
140 Listeners
Mayo Clinic Talks
289 Listeners
The Good GP
21 Listeners
BMJ Best Practice Podcast
26 Listeners
The Zero to Finals Medical Revision Podcast
143 Listeners
The Clinical Problem Solvers
514 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
368 Listeners
Primary Care Knowledge Boost
50 Listeners
GPnotebook Podcast
21 Listeners
What's That Rash?
242 Listeners
Dev Raga Personal Finance
12 Listeners